Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51.
To investigate the biological consequences of aberrant BRCA2 protein during mammary carcinogenesis, we attempted to identify proteins that normally interact with BRCA2. By using a yeast two-hybrid system with a hybrid protein that contained residues 639-1,508 of BRCA2 protein fused to the GAL4 DNA-binding domain, we isolated five independent cDNA clones that encoded parts of RAD51 protein, a human homolog of bacterial RecA. In vitro experiments using anti-RAD51 antibody confirmed interaction of BRCA2 with RAD51. The RAD51-binding region of BRCA2 detected in the present study was distinct from the region reported recently. Further studies using smaller portions of BRCA2 defined at least two additional RAD51-binding domains, residues 982-1,066 and 1,139-1,266. Our results suggest that BRCA2 can interact with RAD51 through multiple sites of BRCA2 and that control of mitotic and meiotic recombination and/or of genomic integrity through binding to RAD51 may be a crucial mechanism by which BRCA2 suppresses abnormal proliferation of mammary cells.
Pubmed ID: 9523196 RIS Download
Amino Acid Sequence | Animals | BRCA2 Protein | Blotting, Western | Breast Neoplasms | DNA Nucleotidyltransferases | DNA Repair | DNA-Binding Proteins | Female | Glutathione Transferase | HeLa Cells | Humans | Mice | Molecular Sequence Data | Neoplasm Proteins | Rad51 Recombinase | Recombinant Fusion Proteins | Saccharomyces cerevisiae | Saccharomyces cerevisiae Proteins | Transcription Factors | Tumor Cells, Cultured